Financials
- Market Capitalization 39.6 M
- Employee 12
- Founded 2001
- CEO Joel Latham
- Website www.incannex.com.au
- Headquarter Delaware, United States
- FIGI BBG01J0814Y2
- Industry Fabricantes de medicamentos — especializados y genéricos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.16
Relación precio/flujo de caja
86.42
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4281 | INCR Intercure Ltd. - ordinary shares | 0.95 USD | -2.06% | -3.06% | +5.56% | -38.71% | 51.95 M USD | ||
| 4353 | SCYX SCYNEXIS, Inc. - Common Stock | 4.48 USD | +2.28% | +1.82% | +5.41% | +453.09% | 44.49 M USD | ||
| 4453 | ZYBT Zhengye Biotechnology Holding Limited - Class A Ordinary Shares | 0.71 USD | -8.97% | +1.43% | -5.33% | -70.90% | 33.65 M USD | ||
| 4550 | CPHI China Pharma Holdings, Inc. Common Stock | 0.60 USD | -3.23% | -9.09% | -24.05% | -9.24% | 24.31 M USD |